α-Synuclein regulation of the dopaminergic transporter:: a possible role in the pathogenesis of Parkinson's disease

被引:138
作者
Sidhu, A
Wersinger, C
Vernier, P
机构
[1] Georgetown Univ, Dept Pediat, Lab Mol Neurochem, Washington, DC 20007 USA
[2] CNRS, Inst Neurobiol Alfred FESSARD, F-91198 Gif Sur Yvette, France
关键词
dopamine transporter; alpha-synuclein; Parkinson's disease; synucleinopathies; 1-methyl-4-phenyl-1 2,3,6-tetrahydropyrimidine; neurodegeneration; Lewy bodies;
D O I
10.1016/j.febslet.2004.03.063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a slow progressive neurodegenerative disorder. Recent evidence suggests a central role for alpha-synuclein, a protein of unknown function, in the genesis of PD. The phenomenon of selective degeneration of dopaminergic neurons in PD may be linked to the potential toxicity of dopamine itself and aberrations in the processes which regulate dopamine content may underlie the pathogenesis of this disease. Here, we review a vital role of alpha-synuclein in the modulation of dopamine transporter (DAT) function, and describe how disruption of this modulatory process permits increased re-uptake of high levels of intracellular dopamine by DAT, causing profound neurotoxicity. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 53 条
[11]   Regulated trafficking of the human dopamine transporter - Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters [J].
Daniels, GM ;
Amara, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35794-35801
[12]   Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP [J].
Dauer, W ;
Kholodilov, N ;
Vila, M ;
Trillat, AC ;
Goodchild, R ;
Larsen, KE ;
Staal, R ;
Tieu, K ;
Schmitz, Y ;
Yuan, CA ;
Rocha, M ;
Jackson-Lewis, V ;
Hersch, S ;
Sulzer, D ;
Przedborski, S ;
Burke, R ;
Hen, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) :14524-14529
[13]   Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease [J].
El-Agnaf, OMA ;
Jakes, R ;
Curran, MD ;
Wallace, A .
FEBS LETTERS, 1998, 440 (1-2) :67-70
[14]   A Drosophila model of Parkinson's disease [J].
Feany, MB ;
Bender, WW .
NATURE, 2000, 404 (6776) :394-398
[15]   Monoamine transporters: From genes to behavior [J].
Gainetdinov, RR ;
Caron, MG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :261-284
[16]   Genetics of Parkinson's disease [J].
Gasser, T .
JOURNAL OF NEUROLOGY, 2001, 248 (10) :833-840
[17]   CHARACTERIZATION OF A NOVEL PROTEIN REGULATED DURING THE CRITICAL PERIOD FOR SONG LEARNING IN THE ZEBRA FINCH [J].
GEORGE, JM ;
JIN, H ;
WOODS, WS ;
CLAYTON, DF .
NEURON, 1995, 15 (02) :361-372
[18]  
George JM, 2002, GENOME BIOL, V3
[19]   Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein [J].
Giasson, BI ;
Duda, JE ;
Quinn, SM ;
Zhang, B ;
Trojanowski, JQ ;
Lee, VMY .
NEURON, 2002, 34 (04) :521-533
[20]  
GRAHAM DG, 1978, MOL PHARMACOL, V14, P633